维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Ramani VC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Proteolytic action of kal- likrein-related peptidase 7 produces unique active matrix metallo- proteinase-9 lacking the C-terminal hemopexin domains 显示文摘	Ramani VC Kaushal GP Haun RS	2011	Bio- ehim Biophys Aeta2011，1813，8：	1
2	Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer显示文摘	Ramani VC Hennings L Hann RS	2008	BMC Cancer2008，17，8：	1
3	The heparanase/syndecan-1 axis in cancer:mechanisms and therapies显示文摘	Ramani VC Purushothaman A Stewart MD	2013	FEBS J2013，280，10：	1
4	Kallikrein 7 enhances pan- creatic cancer cell invasion by shedding Ecadherin 显示文摘	Johnson SK Ramani VC Hennings L	2007	Cancer2007，109，9：	1
5	The extracellular matrix protein fibronectin is a substrate for kallikrein 7 显示文摘	Ramani VC Haun RS	2008	Biochem Biophys Res Commun2008，369，4：	1
6	Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin显示文摘	Johnson SK Ramani VC Hennings L	2007	Cancer2007，109，9：	1
7	Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer显示文摘	Ramani VC Hennings L Haun RS	2008	BMC Cancer2008，17，8：	1
8	Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin显示文摘	Johnson SK Ramani VC Hennings L	2007	Cancer2007，109，9：	1
9	Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin显示文摘	Johnson SK Ramani VC Hennings L	2007	Cancer2007，109，9：	1
10	The extracellular matrix protein fibronectin is a substrate for kallikrein 7显示文摘	Ramani VC Haun RS	2008	Biochem Biophys Res Commun2008，369，4：	1
11	Kallikrein 7 enhancespancreatic cancer cell invasion by shedding E-cadherin显示文摘	Johnson SK Ramani VC Hennings L	2007	Canc-er2007，109，9：	1
12	Heparanase enhanceslocal and systemic osteolysis in multiple myeloma by up- regulating the expression and secretion of RANKL 显示文摘	Yang Y Ren Y Ramani VC	2010	Cancer Res2010，70，21：	1
13	Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes显示文摘	Thompson CA Purushothaman A Ramani VC	2013	J Biol Chem2013，288，10：	1
14	Circulating tumor cell technologies显示文摘	Ferreira MM Ramani VC Jeffrey SS	2016	Mol Oncol2016，10，3：	1
15	The heparanase/syndecan-1 axis in cancer: mechanisms and therapies 显示文摘	Ramani VC Purushothaman A Stewart MP	2013	FEBS J2013，280，10：	1
16	The extracellular matrix protein fibronectin is a substrate for kallikrein 7 显示文摘	Ramani VC Haun RS	2008	Biochem Biophys Res Commun2008，369，4：	1
17	The hepara-nase/syndecan-laxis in cancer: mechanisms and therapies 显示文摘	Ramani VC Purushothaman A Stewart MD	2013	FEBS J2013，280，10：	1
18	The hep-aranase/syndecan-1 axis in cancer: mechanisms and ther- apies显示文摘	Ramani VC Purushothaman A Stewart MD et d	2013	FEBS J2013，280，10：	1
19	The extracellular matrix protein fibronectin is a substrate for kallikrein 7显示文摘	Ramani VC Haun RS	2008	Biochem Biophys Res Commun2008，369，4：	1
20	SST0001, a chemicallymodified heparin, inhibits myeloma growth and angiogenesis viadisruption of the heparanase/syndecan-1 axis显示文摘	Ritchie JP Ramani VC Ren Y	2011	Clin Cancer Res2011，17，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示